Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleContinuing Education

Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies

Julie Bolin
Journal of Nuclear Medicine Technology September 2021, 49 (3) 199-208; DOI: https://doi.org/10.2967/jnmt.120.257105
Julie Bolin
Nuclear Medicine Technology Program, GateWay Community College, Phoenix, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 49 no. 3 199-208
DOI 
https://doi.org/10.2967/jnmt.120.257105
PubMed 
34244225

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication September 17, 2020
  • Accepted for publication April 14, 2021
  • Published online September 3, 2021.

Article Versions

  • previous version (July 9, 2021 - 14:50).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Julie Bolin
  1. Nuclear Medicine Technology Program, GateWay Community College, Phoenix, Arizona
  1. For correspondence or reprints, contact Julie Bolin (julie.bolin{at}gatewaycc.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
    Simona D’Aprile, Simona Denaro, Anna Maria Pavone, Sebastiano Giallongo, Cesarina Giallongo, Alfio Distefano, Lucia Salvatorelli, Filippo Torrisi, Raffaella Giuffrida, Stefano Forte, Daniele Tibullo, Giovanni Li Volti, Gaetano Magro, Nunzio Vicario, Rosalba Parenti
    Journal of Translational Medicine 2023 21 1
  • Multi-Omics and Management of Follicular Carcinoma of the Thyroid
    Thifhelimbilu Emmanuel Luvhengo, Ifongo Bombil, Arian Mokhtari, Maeyane Stephens Moeng, Demetra Demetriou, Claire Sanders, Zodwa Dlamini
    Biomedicines 2023 11 4
  • Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies
    Jędrzej Borowczak, Dariusz Łaszczych, Katarzyna Olejnik, Jakub Michalski, Anna Gutowska, Monika Kula, Anita Bator, Marta Sekielska-Domanowska, Roman Makarewicz, Andrzej Marszałek, Łukasz Szylberg, Magdalena Bodnar
    Pharmaceuticals 2024 17 10

Article usage

Article usage: July 2021 to April 2025

AbstractFullPdf
Jul 202149901
Aug 202116502
Sep 202124432854
Oct 202117817238
Nov 202113219144
Dec 2021563923
Jan 2022876033
Feb 2022408331
Mar 2022536426
Apr 2022456632
May 2022305541
Jun 2022468648
Jul 2022287619
Aug 2022318628
Sep 20225614230
Oct 20223219632
Nov 20222120418
Dec 20222119720
Jan 20233226114
Feb 20233224518
Mar 20233530424
Apr 20231423723
May 20231824319
Jun 20231928121
Jul 20231934821
Aug 20232334025
Sep 20232928617
Oct 20231636619
Nov 2023734721
Dec 2023930512
Jan 2024738316
Feb 2024184059
Mar 20241635737
Apr 2024932028
May 20241136720
Jun 20241630125
Jul 20241349827
Aug 20242633744
Sep 20243635144
Oct 20241237330
Nov 20242337128
Dec 2024835916
Jan 2025733226
Feb 2025936813
Mar 20251737640
Apr 20253439949
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 49 (3)
Journal of Nuclear Medicine Technology
Vol. 49, Issue 3
September 1, 2021
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies
Julie Bolin
Journal of Nuclear Medicine Technology Sep 2021, 49 (3) 199-208; DOI: 10.2967/jnmt.120.257105

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies
Julie Bolin
Journal of Nuclear Medicine Technology Sep 2021, 49 (3) 199-208; DOI: 10.2967/jnmt.120.257105
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • THE BASICS
    • PRESERVATION OF CELL TYPE
    • OVERVIEW OF FOLLICULAR EPITHELIAL CELL–DERIVED THYROID CANCERS
    • GENETIC CHANGES INVOLVED IN THYROID CARCINOGENESIS
    • NON-MAPK GENETIC MUTATIONS
    • ASSESSMENT AND TREATMENT
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Once Again--The SNMMI "Nailed It"!
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • anaplastic thyroid carcinoma
  • follicular thyroid carcinoma
  • papillary thyroid carcinoma
  • mitogen activated protein kinase
  • ATC
  • FTC
SNMMI

© 2025 SNMMI

Powered by HighWire